核医学在前列腺癌成像和治疗中的作用：最新技术。

IF 2.4 4区医学 Q2 UROLOGY & NEPHROLOGY

Urologic Clinics of North America Pub Date : 2024-10-10 DOI:10.1016/j.ucl.2024.07.004

Gregory Peters-Founshtein MD, PhD , Yael Eshet MD, MSc , Michal Sarfaty MD , Zohar Dotan MD, PhD , Onofrio Antonio Catalano MD, PhD , Tima Davidson MD , Liran Domachevsky MD

引用次数: 0

摘要

前列腺癌（PCa）是男性诊断率第二高的癌症。近年来，核医学在前列腺癌的诊断、分期、监测和治疗中发挥着越来越重要的作用。特别是前列腺特异性膜抗原 PET/计算机断层扫描的引入，为检测局部和远处疾病做出了重大贡献。放射性配体疗法具有高度选择性的细胞毒性作用，正逐步融入 PCa 治疗中。新型治疗药物的出现、更多适应症的出现以及核成像与治疗之间更全面的整合，代表了 PCa 核医学的前沿。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

The Role of Nuclear Medicine in Imaging and Therapy of Prostate Cancer

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Urologic Clinics of North America 医学-泌尿学与肾脏学

CiteScore

4.50

自引率

4.20%

发文量

审稿时长

6-12 weeks

期刊介绍： For 30 years, Urologic Clinics of North America has provided important clinical updates on the entire spectrum of urology. Each quarterly issue (February, May, August, and November) focuses on a specific topic, with review articles written by leading experts in the field. Topics include adult and pediatric clinical urology, as well as surgical oncology, radiology, pathology, erectile dysfunction, infertility, incontinence, transplantation, endourology, andrology, female urology, reconstructive surgery, and medical oncology.